Acasti Pharma | ACST - Current Liabilities

Stock Price
3.73
Daily Change
-0.02 -0.53%
Monthly
2.76%
Yearly
15.84%
Q1 Forecast
3.54

Acasti Pharma reported $1.24M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acasti Pharma USD 1.24M 1.08M Sep/2025
Addus HomeCare USD 156.8M 5.42M Sep/2025
Amarin USD 182.23M 3.71M Sep/2025
Cassava Sciences USD 48.05M 716K Sep/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Option Care Health USD 823.91M 50.29M Sep/2025
Organigram Holdings CAD 126.16M 18.88M Sep/2025
Tilray USD 280.3M 18.13M Mar/2025